ATE198276T1 - Verwendung von lanthanide-, zinn-, mangan-, yttrium-, kobalt-, barium-, strontiumsalzen in einem hautpflegemittel - Google Patents
Verwendung von lanthanide-, zinn-, mangan-, yttrium-, kobalt-, barium-, strontiumsalzen in einem hautpflegemittelInfo
- Publication number
- ATE198276T1 ATE198276T1 AT96402180T AT96402180T ATE198276T1 AT E198276 T1 ATE198276 T1 AT E198276T1 AT 96402180 T AT96402180 T AT 96402180T AT 96402180 T AT96402180 T AT 96402180T AT E198276 T1 ATE198276 T1 AT E198276T1
- Authority
- AT
- Austria
- Prior art keywords
- yttrium
- barium
- cobalt
- tin
- manganeous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9512656A FR2740341B1 (fr) | 1995-10-26 | 1995-10-26 | Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE198276T1 true ATE198276T1 (de) | 2001-01-15 |
Family
ID=9483957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96402180T ATE198276T1 (de) | 1995-10-26 | 1996-10-14 | Verwendung von lanthanide-, zinn-, mangan-, yttrium-, kobalt-, barium-, strontiumsalzen in einem hautpflegemittel |
Country Status (9)
Country | Link |
---|---|
US (1) | US5866168A (de) |
EP (1) | EP0775492B1 (de) |
JP (1) | JPH09169657A (de) |
AT (1) | ATE198276T1 (de) |
CA (1) | CA2188688C (de) |
DE (1) | DE69611343T2 (de) |
ES (1) | ES2155179T3 (de) |
FR (1) | FR2740341B1 (de) |
NO (1) | NO319503B1 (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6203803B1 (en) | 1994-12-14 | 2001-03-20 | Societe L'oreal S.A. | Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained |
US7404967B2 (en) * | 1994-12-21 | 2008-07-29 | Cosmederm, Inc. | Topical product formulations containing strontium for reducing skin irritation |
US6139850A (en) * | 1994-12-21 | 2000-10-31 | Cosmederm Technologies | Formulations and methods for reducing skin irritation |
FR2740340B1 (fr) * | 1995-10-30 | 1997-12-05 | Oreal | Utilisation d'acides carboxyliques porteurs d'une fonction soufree pour favoriser la desquamation de la peau ou stimuler le renouvellement epidermique |
US6168798B1 (en) * | 1997-02-03 | 2001-01-02 | Bristol-Myers Squibb Company | Non-irritating composition for treating acne and other skin conditions |
US6248370B1 (en) * | 1997-07-24 | 2001-06-19 | Leroy Harris | Skin treatment and methods |
AT405017B (de) * | 1997-10-06 | 1999-04-26 | Jakoby Marie Luise | Mittel zur stimulation der körpereigenen abwehr |
FR2774285B1 (fr) * | 1998-02-03 | 2001-06-15 | Roche Posay Lab Pharma | Utilisation d'une composition cosmetique pour le traitement et la prevention de la rosacee |
WO2001003712A1 (en) * | 1999-07-09 | 2001-01-18 | Astion Development Aps | Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement |
DE10043466A1 (de) * | 2000-09-04 | 2002-03-28 | Johannes Wohlrab | Manganverbindungen enthaltende Zubereitung zur topischen Applikation und deren Verwendungen |
ES2181586B1 (es) * | 2001-05-03 | 2004-06-16 | Alfonso Blanco Cobo | Producto farmaceutico para el tratamiento de tumores cancerigenos. |
NO20014746D0 (no) * | 2001-09-28 | 2001-09-28 | Clas M Kjoelberg | Smertelindrende middel |
US7879365B2 (en) * | 2002-02-07 | 2011-02-01 | The Trustees Of Columbia University In The City Of New York | Zinc salt compositions for the prevention of dermal and mucosal irritation |
JP2005527601A (ja) * | 2002-04-30 | 2005-09-15 | 久光製薬株式会社 | 二糖類及び金属イオンによる、刺激の阻止のための方法及び組成物 |
US7081247B2 (en) * | 2002-05-20 | 2006-07-25 | Nidaria Technology Ltd. | Composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting |
FR2846558B1 (fr) * | 2002-11-05 | 2006-07-14 | Servier Lab | Utilisation du sel distrontique de l'acide 2-n,n-di(carboxymethyl)amino-3-cyano-4-carboxymethyl- thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales |
AU2002365172A1 (en) * | 2002-12-09 | 2004-06-30 | Evgeny Nikolaevich Ananiev | Pharmaceutical or cosmetic composition, preventing or reducing itch and local reaction from stings of insects |
EP2995312A1 (de) * | 2003-03-27 | 2016-03-16 | SantoSolve AS | Entzündungshemmende zusammensetzung auf der basis von strontiumverbindungen |
ATE342722T1 (de) * | 2003-05-07 | 2006-11-15 | Osteologix As | Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen |
AU2004237438B2 (en) * | 2003-05-07 | 2011-01-20 | Osteologix A/S | Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions |
WO2005009352A2 (en) * | 2003-07-17 | 2005-02-03 | The Trustees Of Columbia University In The City Of New York | Antimicrobial compositons containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof |
EP1523985B1 (de) * | 2003-10-17 | 2010-03-10 | Oy Neurofood Ab | Nicht-radioaktives Strontiummittel zur Behandlung von Krebs |
WO2005053613A2 (en) * | 2003-11-26 | 2005-06-16 | Combinatorx, Inc. | Combinations for the treatment of fungal infections |
US7258875B2 (en) * | 2003-12-04 | 2007-08-21 | Chiou Consulting, Inc. | Compositions and methods for topical treatment of skin infection |
FR2866810B1 (fr) * | 2004-03-01 | 2006-04-28 | Oreal | Utilisation d'au moins un inhibiteur des canaux calciques pour prevenir et/ou traiter la peau grasse. |
GB0517043D0 (en) * | 2005-08-19 | 2005-09-28 | York Pharma Plc | Improvements in pharmaceutical compositions |
US20070154448A1 (en) | 2005-11-22 | 2007-07-05 | Ted Reid | Methods and compositions using Substance P to promote wound healing |
JP2010501551A (ja) * | 2006-08-25 | 2010-01-21 | テウン イーエルエス インコーポレイテッド | 毛髪改善のための希土類元素の用途 |
KR100769260B1 (ko) * | 2006-08-25 | 2007-10-22 | 주식회사 태웅이엘에스 | 희토원소를 함유하는 모발 개선용 조성물 |
GB0617191D0 (en) * | 2006-08-31 | 2006-10-11 | York Pharma Plc | Improvements in pharmaceutical compositions |
WO2013142383A1 (en) | 2012-03-21 | 2013-09-26 | Cosmederm Bioscience, Inc. | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation |
WO2016141219A1 (en) * | 2015-03-05 | 2016-09-09 | Cosmederm Bioscience, Inc. | Strontium based compositions and formulations for pain, pruritus, and inflammation |
US11235002B2 (en) | 2015-08-21 | 2022-02-01 | Galleon Labs Llc | Strontium based compositions and formulations for pain, pruritus, and inflammation |
WO2020091699A1 (en) | 2018-10-31 | 2020-05-07 | Yeditepe Universitesi | Use of nano-sized lanthanide borate (dysprosium borate and erbium borate) compounds for wound healing purposes and production method thereof |
EP3999076A4 (de) * | 2019-07-18 | 2023-08-09 | The Regents of the University of California | Zusammensetzungen und verfahren zur behandlung von hauterkrankungen |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE297062C (de) * | ||||
GB997975A (en) * | 1964-01-31 | 1965-07-14 | Aristotelis Papageorgiou Lambo | Pharmaceutical compositions containing a cresol or a mixture of cresols |
GB1072355A (en) * | 1964-06-17 | 1967-06-14 | Michael Collin | Antiseptic and anti-pruretic solution containing camphor |
US3519711A (en) * | 1967-09-01 | 1970-07-07 | Robert E Svigals | Composition and method of treating pruritic conditions of the skin |
IE35991B1 (en) * | 1971-01-22 | 1976-07-21 | Comprehensive Pharmaceuticals | Improvements in or relating to the treatment of diseases of the skin and mucosa |
LU65373A1 (de) * | 1972-05-17 | 1973-11-23 | ||
US3888976A (en) * | 1972-09-21 | 1975-06-10 | William P Mlkvy | Zinc and strontium ion containing effervescent mouthwash tablet |
US3772431A (en) * | 1972-09-21 | 1973-11-13 | W Mlkvy | Effervescent mouthwash tablet |
US4477439A (en) * | 1981-04-13 | 1984-10-16 | Walter J. Monacelli | Treatment of irritated and excoriated areas around the stoma of ostomy patients |
JPS58501675A (ja) * | 1981-10-09 | 1983-10-06 | フエ−リング・ア−ベ− | 物質p「きつ」抗質からなる薬材 |
AU556817B2 (en) * | 1982-02-03 | 1986-11-20 | Efamol Limited | Topical application of a lithium salt and dihomo-alpha- linolenic acid |
GB8320203D0 (en) * | 1983-07-27 | 1983-09-01 | Horrobin D F | Anti-viral compositions |
DE3338957A1 (de) * | 1983-10-27 | 1985-05-15 | Keyhan Dipl.-Ing. 6908 Wiesloch Ghawami | Enthaarungsmittel |
US4711780A (en) * | 1984-06-11 | 1987-12-08 | Fahim Mostafa S | Composition and process for promoting epithelial regeneration |
IT1214611B (it) * | 1985-05-22 | 1990-01-18 | Schiena Ricerche | Composti per uso cosmetico dermatologico e relative composizioni. |
US4837026A (en) * | 1985-10-03 | 1989-06-06 | Rajakhyaksha Vithal J | Transdermal and systemic preparation and method |
ATE69954T1 (de) * | 1985-10-08 | 1991-12-15 | Psori Med Ag | Salzmischung zur behandlung der schuppenflechte (psoriasis) und anderer hautkrankheiten. |
US4735802A (en) * | 1986-05-05 | 1988-04-05 | Le Bich N | Topical dermatological composition and method of treatment |
FR2599967B1 (fr) * | 1986-06-16 | 1989-03-31 | Bfb Etudes Rech Experimentale | Utilisation de sel de zinc et de la vitamine b6 pour enrayer les processus alopeciques et/ou seborrheiques. |
US4986981A (en) * | 1986-07-07 | 1991-01-22 | Den Mat Corporation | Toothpaste having low abrasion |
US5091171B2 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
SE8701372L (sv) * | 1987-04-02 | 1988-10-03 | Boliden Ab | Foerfarande och medel foer konservering av hoe |
DE3929411A1 (de) * | 1988-09-22 | 1990-03-29 | Siegfried Natterer | Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung |
FR2644063B1 (fr) * | 1989-03-13 | 1991-06-14 | Fabre Pierre Cosmetique | Compositions dermatologiques et cosmetologiques a base d'alcoylcarboxamide et de sel de zinc utiles dans le traitement de la dermite seborrheique et/ou des troubles de la seborrhee |
CA2014201A1 (en) * | 1989-04-26 | 1990-10-26 | Albemarle Corporation | Solid non-hygroscopic trialkylamine oxides |
DE69007486T2 (de) * | 1989-07-31 | 1994-08-11 | Massachusetts Institute Of Technology, Cambridge, Mass. | Verwendung von calciumantagonisten für die behandlung von narben. |
US5132119A (en) * | 1989-07-31 | 1992-07-21 | Massachusetts Institute Of Technology | Treatment of hypertrophic wound healing disorders with calcium channel blockers |
IL95393A0 (en) * | 1989-08-18 | 1991-06-30 | John Morris Co | Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing |
US5202130A (en) * | 1989-08-31 | 1993-04-13 | The Johns Hopkins University | Suppression of eczematous dermatitis by calcium transport inhibition |
US5296476A (en) * | 1989-09-08 | 1994-03-22 | Henderson Esther G | Skin care compositions |
EP0439640B1 (de) * | 1990-01-29 | 1993-09-15 | WOGEPHARM GmbH | Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen |
EP0451300B1 (de) * | 1990-04-10 | 1994-10-26 | Romuald Dr. Kowalski | Bariumsulfat-kolloidale Dispersion enthaltende Zusammensetzung |
FR2662607B1 (fr) * | 1990-05-30 | 1992-08-28 | Oreal | Composition destinee a etre utilisee pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives d'alkyl-2 amino-4 (ou dialkyl-2-4) pyrimidine oxyde-3 . |
ATE133657T1 (de) * | 1991-07-05 | 1996-02-15 | Merck Sharp & Dohme | Aromatische verbindungen, diese enthaltende pharmazeutische zusammensetzungen und ihre therapeutische anwendung |
DE69208089T2 (de) * | 1991-07-10 | 1996-08-22 | Merck Sharp & Dohme | Aromatische verbindungen diese enthaltende pharmazeutische zusammensetzungen und ihre therapeutische verwendung |
RU2038072C1 (ru) * | 1991-11-01 | 1995-06-27 | Государственный российский научно-исследовательский институт органической химии и технологии | Крем для защиты кожи от химических веществ и способ его получения |
GB9201179D0 (en) * | 1992-01-21 | 1992-03-11 | Glaxo Group Ltd | Chemical compounds |
DE9211006U1 (de) * | 1992-08-17 | 1993-12-16 | Kao Corporation GmbH, 40472 Düsseldorf | Mittel zur Haarbehandlung |
GB9222486D0 (en) * | 1992-10-26 | 1992-12-09 | Merck Sharp & Dohme | Therapeutic agents |
WO1994009798A1 (en) * | 1992-10-29 | 1994-05-11 | C-P Technology Limited Partnership | Mixtures or complexes containing calcium and sulfate |
US5593992A (en) * | 1993-07-16 | 1997-01-14 | Smithkline Beecham Corporation | Compounds |
WO1996019182A1 (en) * | 1994-12-21 | 1996-06-27 | Cosmederm Technologies | Formulations and methods for reducing skin irritation |
US5716625A (en) * | 1994-12-21 | 1998-02-10 | Cosmederm Technologies | Formulations and methods for reducing skin irritation |
ES2192586T3 (es) * | 1994-12-21 | 2003-10-16 | Cosmederm Technologies | Formulaciones y procedimientos para reducir la irritacion de la piel. |
DE4446521A1 (de) * | 1994-12-24 | 1996-06-27 | Estee Lauder Inc | Mascara-Bürstchen |
-
1995
- 1995-10-26 FR FR9512656A patent/FR2740341B1/fr not_active Expired - Fee Related
-
1996
- 1996-10-14 AT AT96402180T patent/ATE198276T1/de active
- 1996-10-14 DE DE69611343T patent/DE69611343T2/de not_active Expired - Fee Related
- 1996-10-14 EP EP96402180A patent/EP0775492B1/de not_active Expired - Lifetime
- 1996-10-14 ES ES96402180T patent/ES2155179T3/es not_active Expired - Lifetime
- 1996-10-23 CA CA002188688A patent/CA2188688C/fr not_active Expired - Fee Related
- 1996-10-24 NO NO19964515A patent/NO319503B1/no unknown
- 1996-10-25 JP JP8284316A patent/JPH09169657A/ja active Pending
- 1996-10-28 US US08/740,311 patent/US5866168A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FR2740341B1 (fr) | 1997-12-19 |
NO964515D0 (no) | 1996-10-24 |
DE69611343D1 (de) | 2001-02-01 |
CA2188688A1 (fr) | 1997-04-27 |
ES2155179T3 (es) | 2001-05-01 |
CA2188688C (fr) | 2002-12-17 |
US5866168A (en) | 1999-02-02 |
DE69611343T2 (de) | 2001-04-26 |
FR2740341A1 (fr) | 1997-04-30 |
NO964515L (no) | 1997-04-28 |
JPH09169657A (ja) | 1997-06-30 |
NO319503B1 (no) | 2005-08-22 |
EP0775492A1 (de) | 1997-05-28 |
EP0775492B1 (de) | 2000-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE198276T1 (de) | Verwendung von lanthanide-, zinn-, mangan-, yttrium-, kobalt-, barium-, strontiumsalzen in einem hautpflegemittel | |
EP0770392A3 (de) | Verwendung von Lanthanide-, Zinn-, Mangan-, Yttrium-, Kobalt-, Barium-, Strontiumsalzen in einer pharmazeutische Zusammensetzung | |
WO2002036534A3 (en) | Processes for preparing linear polyglycerols and polyglycerol esters | |
EP2338448A3 (de) | Antiinflammatorische und antimikrobielle Verwendungen von bioaktiven Glaszusammensetzungen | |
DE3687099D1 (de) | Verwendung von einem cartilago-induzierenden faktor (cif) zur herstellung eines arzneimittels zur behandlung von entzuendungen. | |
ATE187646T1 (de) | Verwendung von kupfer enthaltenden wirkstoffen zur beschleunigung der wundheilung | |
PT1161248E (pt) | Composição farmacêutica que contém uma fonte de nitrato e um agente acidificante destinada ao tratamento de feridas abertas e queimaduras | |
DE69700180D1 (de) | Kosmetische und/oder dermatologische Zusammensetzung, die mindestens einen Wirkstoffvorläufer und mindestens eine vernetzte Poly(2-acrylamido-2-methylpropansulfonsäure) enthält | |
IS4328A (is) | Fjöleininga lyfjablanda sem inniheldur prótónupumpublokkara | |
CA2106073A1 (en) | Composition for promoting tissue repair and regeneration | |
GR3021424T3 (en) | Use of 3-guanidinopropionic acid in the manufacture of a medicament for the treatment and prevention of excess adiposity | |
AU4917993A (en) | Stabilized sorbic acid or salt thereof | |
DE60016460D1 (de) | Verwendungen und zusammenstellungen von nitratestern als sedativa | |
EP0596838A3 (en) | Esters of l-carnitine and alkanoyl l-carnitines with glycolic acid or esters thereof and pharmaceutical compositions containing same for treating dermatoses. | |
IL110808A (en) | Pharmaceutical compositions containing aromatic and araliphatic carboxylic acid derivatives for treating light and age-damaged skin and for promoting wound healing and some novel such compounds | |
EP0934748A3 (de) | Von Willenbrand Faktor (vWF) enthaltende Zubereitung, verfahren zür Herstellung von vWF enthaltenden Zubereitungen und deren Verwendung | |
ES2132082T3 (es) | Composiciones para cicatrizar heridas que contienen el factor de crecimiento fibroplasto y acido ascorbico. | |
CA2059558A1 (en) | Use of calcium antagonists for treating scars | |
EP0770391A3 (de) | Verwendung von Lanthanide-, Zinn-, Mangan-, Yttrium-, Kobalt-, Barium-, Strontiumsalzen in pharmazeutische Zubereitungen | |
EP0587106A3 (en) | Lipophilic salts containing neutron activable isotopes and compositions containing them | |
GB2260702B (en) | Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X | |
DE69922471D1 (de) | Topische Borneol und Wismutgallat enthaltende pharmazeutische Zubereitungen zur Wundheilung | |
CA2144127A1 (fr) | Composition pour lutter contre les taches et/ou le vieillissement de la peau, ses utilisations | |
RU93017673A (ru) | Люминесцентный материал и способ приготовления пропиточного раствора | |
TH14003A (th) | การนำส่งยาทางผิวหนังที่ถูกปรับปรุงขึ้น |